Some of these autoantibodies are frequently detected in patients with connective tissue diseases overlapping myositis, especially systemic sclerosis, and are referred to as myositis-associated autoantibodies (MAAs). The gene discussed is MAPKAPK5-AS1; the disease is myositis disease.